Go to Top
X

Media Room

  • AUTHENTIDATE HOLDING CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements

    ADAt files SEC form 8-K

    As previously reported, (i) on November 18, 2015, Authentidate Holding Corp. (the "Company") entered into an agreement and plan of merger with and a newly formed acquisition subsidiary of the Company and Peachstate Health Management LLC, d/b/a AEON Clinical Laboratories ("AEON"), (ii) on January 26, 2016, the parties executed an Amended and Restated Agreement and Plan of Merger.
    Read More
  • Authentidate Holding Corp. Announces Reverse Stock Split

    Common stock will begin trading on a split-adjusted basis on January 25, 2016 Stockholders also Approve Amendment to Certificate of Incorporation to Preserve Tax Benefits

    Authentidate Holding Corp. (Nasdaq: ADAT) today announced a 1-for-9 reverse split of its common stock. The reverse stock split will become effective at 5:00 p.m. Eastern Time today, January 22, 2016 and Authentidate’s common stock will begin trading on The NASDAQ Capital Market on a split-adjusted basis when the market opens on January 25, 2016.
    Read More
  • Authentidate and AEON Clinical Laboratories Enter Into Non-Binding Letter Of Intent to Merge

    Authentidate Holding Corp. and AEON Clinical Laboratories today announced that the companies have entered into a non-binding letter of intent (the “Letter of Intent”) for the acquisition of all of the outstanding membership interests of AEON in exchange for shares of a newly created class of Series E Preferred Stock of Authentidate (the “Series E Shares”).
    Read More
  • Authentidate Holding Corp. and AEON Clinical Laboratories Announce Execution of Definitive Merger Agreement

    Authentidate Holding Corp. (NASDAQ: ADAT) and Peachstate Health Management, LLC d/b/a AEON Clinical Laboratories today announced that they have entered into a definitive merger agreement under which privately-held AEON will merge with a wholly-owned subsidiary of Authentidate in exchange for shares of a newly created class of Series E Preferred Stock of Authentidate.
    Read More
  • Authentidate and AEON Clinical Laboratories Complete Merger to Form Innovative Healthcare Technology Company

    Sonny Roshan to serve as Chairman of the Board; Richard Hersperger appointed CEO of the combined Company

    Authentidate Holding Corp. and AEON Clinical Laboratories, today announced that they have completed their merger transaction whereby privately-held AEON has merged with a wholly-owned subsidiary of Authentidate. The merger creates a company focused on delivering innovative solutions that achieve technology best practices in medicine and raise the standard of healthcare.
    Read More